U.S. regulators on Monday approved the first RSV vaccine for pregnant women so their babies will be born with protection against the scary respiratory...
RSV is a coldlike nuisance for most healthy people but it can be life-threatening for the very young. It inflames babies’ tiny airways so it’s hard to breathe or causes pneumonia. In the U.S. alone, between 58,000 and 80,000 children younger than 5 are hospitalized each year, and several hundred die, from the respiratory syncytial virus.Advertisement
It’s the same way pregnant women pass along protection against other infections. Pregnant women have long been urged to get a flu shot and a whooping cough vaccine — and more recently, COVID-19 vaccination. The only other option to guard babies from RSV: Giving them lab-made antibodies. The FDA recently approved a that’s the first one-dose version, recommended for all infants younger than 8 months before their first RSV season starts. Beyfortus, from Sanofi and AstraZeneca, is expected to be available this fall.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
FDA approves RSV vaccine for moms-to-be to guard their newbornsU.S. regulators have approved the first RSV vaccine for pregnant women to protect their newborns.
Lire la suite »
FDA approves RSV vaccine for moms-to-be to guard their newbornsU.S. regulators have approved the first RSV vaccine for pregnant women to protect their newborns
Lire la suite »
FDA approves RSV vaccine for moms-to-be to guard their newbornsU.S. regulators have approved the first RSV vaccine for pregnant women to protect their newborns.
Lire la suite »
FDA approves RSV vaccine for moms-to-be to guard their newbornsU.S. regulators have approved the first RSV vaccine for pregnant women to protect their newborns.
Lire la suite »
FDA approves RSV vaccine for pregnant women to guard their newbornsPfizer’s vaccine, given in late pregnancy, allows moms-to-be to develop virus-fighting antibodies that pass to their fetus.
Lire la suite »